Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 303 clinical trials
Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer

This phase I trial studies how well cemiplimab before and after surgery works in treating patients with high risk cutaneous squamous cell cancer. Immunotherapy with monoclonal antibodies, such as cemiplimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow …

extranodal extension
hormone replacement therapy
primary lesion
heparin
monoclonal antibodies
  • 0 views
  • 19 Feb, 2024
  • 1 location
Cohort of Patients With Systemic Sclerosis Within the Framework of the RESO Reference Centre

Systemic sclerosis (SSc) is a rare form of connective tissue disease characterized by vascular involvement and the intensity of fibrosis. The lack of available treatment is largely due to the very fragmented understanding of the pathophysiology of SSc. However, one of the keys to conducting quality research on this disease …

rheumatism
scleroderma
fibrosis
progressive systemic sclerosis
  • 0 views
  • 19 Feb, 2024
  • 1 location
Neoadjuvant T-VEC in High Risk Early Melanoma

Despite the recent notable advances in the treatment of advanced melanoma with application of growing immunotherapies, patterns of response and factors resulting in treatment failure are poorly understood. Moreover, the application of these therapeutics has been limited in the neoadjuvant setting, particularly in earlier stage disease, even though this strategy …

cancer
primary tumor
advanced melanoma
immunotherapies
systemic therapy
  • 0 views
  • 19 Feb, 2024
  • 1 location
Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis

They will have repeats of the screening tests. They will also have 2 skin biopsies. These will be from both lesions and unaffected areas. The areas will be injected with a numbing medicine. A round cutting device will remove small pieces of skin from each area.

vitamins
nicotinamide
chronic inflammation
psoriasis
body mass index
  • 0 views
  • 19 Feb, 2024
  • 1 location
Full Metall Jacket Multilevel Segment

Hypothesis: "Total" endovascular revascularization of a multistory lesion of the iliac-femoral-popliteal segment is safer and a better quality of life is achieved in comparison with hybrid intervention. The lack of damage to the skin avoids complications in the postoperative and remote periods of observation, thereby improving the quality of life

  • 0 views
  • 19 Feb, 2024
  • 1 location
HidraWear AX HS Study

The product, HidraWear AX is and adhesive free wound dressing system for the every day home care of Hidradenitis Suppurativa (HS), a debilitating disease of the skin for which there are limited wound dressing products. This is a study to assess the use HidraWear Ax vs current product and method …

hidradenitis
  • 0 views
  • 19 Feb, 2024
  • 1 location
Post Market Usability Evaluation Of The PicoSure Pro Device

The intended use of the PicoSure and PicoSure Pro devices used in this study is to treat additional patients with the new PicoSure Pro device and collect additional data on the devices.

  • 0 views
  • 19 Feb, 2024
  • 2 locations
Physiological Changes Induced Through MEP Conditioning in People With SCI

Research participants will be asked to stand, sit, and walk during the study sessions. Electrodes are placed on the skin over leg muscles for monitoring muscle activity. For examining brain-to-muscle connections, the study team will use transcranial magnetic stimulation.

nervous
neurologic findings
nervous system
spasticity
traumatic brain injury
  • 0 views
  • 19 Feb, 2024
  • 1 location
Dose Escalation of DF6002 in Patients With Advanced Solid Tumors and Expansion in Selected Indications

This study is a Phase 1/2, open-label, dose-escalation study with a consecutive parallel-group efficacy expansion study, designed to determine the safety, tolerability, PK, pharmacodynamics, and preliminary anti-tumor activity of DF6002 as monotherapy and in combination with pembrolizumab.

triple negative breast cancer
adjuvant
transitional cell carcinoma
measurable disease
esophageal carcinoma
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study to Look at How Safe NNC0472-0147 is in Healthy People and in People With Type 2 Diabetes

Participants will get once daily injections of either NNC0472-0147 or insulin glargine for a treatment period of fourteen days. The injections will be given under the skin (subcutaneously, s.c.) of the left thigh. Participants will be in the study for about 7 weeks. There will be 15 visits with the …

diabetes
insulin
type 1 diabetes mellitus
bilateral salpingectomy
bilateral oophorectomy
  • 0 views
  • 19 Feb, 2024
  • 2 locations